Anson Funds Management LP Myriad Genetics Inc Call Options Transaction History
Anson Funds Management LP
- $542 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MYGN
# of Institutions
237Shares Held
95.4MCall Options Held
460KPut Options Held
14.2K-
Black Rock Inc. New York, NY15.2MShares$120 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.26MShares$73.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.92MShares$38.9 Million0.01% of portfolio
-
State Street Corp Boston, MA4.81MShares$38 Million0.0% of portfolio
-
Glenview Capital Management, LLC New York, NY4.59MShares$36.2 Million0.69% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $637M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...